Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties
US9682137B2 · kind B2 · utility
0Cited by
0References
10Claims
0Family size
Assignees
Inventor
Key dates
| Filing date | Dec 7, 2012 |
| Grant date | Jun 20, 2017 |
| Priority date | — |
| Expiry date | Feb 4, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16134
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition includes, as active substance a mutated lentiviral ENV protein, substantially devoid of immunosuppressive properties or a variant of the mutated lentiviral ENV protein or a fragment of the above proteins, in association with a pharmaceutically acceptable carrier.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.